CYIG

 
Common Stock SEC Reporting - Current
OTCQB
Verified Company Profile 1/13/2017
Contact Info
  • co Shandong Spring Pharmaceutical Co.
  • Economic Development Zone
  • Gucheng Road, Sishui County
  • Shandong Province 373200
  • China

Business Description


 
Financial Reporting/Disclosure
Reporting Status U.S. Reporting: SEC Reporting
Audited Financials Audited
Latest Report Dec 31, 2016 10-Q
CIK 0000847464
Fiscal Year End 3/31
OTC Marketplace OTCQB
Profile Data
SIC - Industry Classification 2834 - Pharmaceutical preparations
Incorporated In: FL, USA
Year of Inc. 1989
Employees 309 a/o Jan 07, 2017
Company Officers/Contacts
Yan Tinghe CEO
Maogang Sun COO, Manufacturing Ops.
Li Chuanmin CFO
Zecheng Shao Vice President, IR
Company Directors
Yan Tinghe Chairman
Robert Fanella
Zhang Jirui
Zhang Wengao
Service Providers
Accounting/Auditing Firm
Paritz & Company, P.A.
15 Warren St.
Suite 25
Hackensack, NJ, 07601
United States
 
Securities Counsel
McLaughlin & Stern, LLP OTCQX Sponsor
260 Madison Avenue
New York, NY, 10016
United States
 
Investor Relations Firm

Not Available
Company History
  • Formerly=itLinkz Group, Inc. until 11-07
  • Formerly=Medical Technology & Innovations, Inc. until 4-07
  • Formerly=Southstar Productions, Inc. until 9-95
CYIG Security Details
Share Structure
Market Value1 $13,691,517 a/o Mar 22, 2017
Authorized Shares 100,000,000 a/o Jan 07, 2017
Outstanding Shares 29,764,168 a/o Feb 07, 2017
-Restricted Not Available
-Unrestricted Not Available
Held at DTC Not Available
Float 20,126,227 a/o Jan 07, 2017
Par Value No Par Value
Transfer Agent(s)
Interwest Transfer Co., Inc.
Shareholders
Shareholders of Record 768 a/o Jan 07, 2017
Short Selling Data
Short Interest 0 (-100%)
Feb 15, 2017
Significant Failures to Deliver No

1Market Value calculated only for respective security